Back to companies
PORTFOLIO
Haya Therapeutics
HAYA Therapeutics is a precision medicines company developing programmable therapeutics that target regulatory RNAs derived from the dark genome – a cell information processing unit. The goal is to reprogram pathological cell states for the treatment of rare, common, chronic and aging-related diseases, including cardiovascular disease and cancer.
Milestones
Founded: 2019 Invested: 2025
Leadership Team
Samir Ounzain Daniel Blessing
HQ
Lausanne, Switzerland
OUR PORTFOLIO
SIMILAR COMPANIES
Meet the companies we’ve backed on their way to creating groundbreaking change.
WE INVEST BECAUSE
WE BELIEVE
Got an idea that could change the world? If you're an early-stage founder with big ambitions, we'd love to hear from you.
